West Pharmaceutical (WST) PT Lowered to $285 at UBS
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $346.61 -0.8%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
UBS analyst Gregg Orrill lowered the price target on West Pharmaceutical (NYSE: WST) to $285.00 (from $390.00) while maintaining a Buy rating.
You May Also Be Interested In
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Greatland Resources Ltd (GGP:AU) PT Lowered to AUD14 at Citi
- Perseus Mining Limited (PRU:AU) (PMNXF) PT Lowered to AUD6.80 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
